Cite
HARVARD Citation
Pfeuffer, S. et al. (2021). Impact of previous disease-modifying treatment on effectiveness and safety outcomes, among patients with multiple sclerosis treated with alemtuzumab. Journal of neurology, neurosurgery and psychiatry. 92 (9), pp. 1007-1013. [Online].